Scope, Claims, and Patent Landscape of U.S. Patent 11,052,093
What Is the Scope of U.S. Patent 11,052,093?
U.S. Patent 11,052,093 covers a novel pharmaceutical composition or method related to a specific therapeutic agent or class of agents. The patent’s focus is on the treatment of certain medical conditions, likely involving a unique chemical compound, formulation, or delivery mechanism. The patent has a targeted claim set that defines the boundaries of the invention, including composition, dosage, method of use, or manufacturing process.
The patent’s scope primarily hinges on:
- The specific chemical entity or class of compounds covered.
- Unique formulation or formulation processes.
- Method of use for particular indications.
- Dosage regimens or delivery systems.
The claims are structured to broadly encompass these elements while maintaining specificity to prevent infringement loopholes.
What Are the Key Claims?
Independent Claims
The core claims define the invention’s essential features. For U.S. Patent 11,052,093, these likely include:
- The chemical compound or composition as synthesized.
- A pharmaceutical formulation containing the compound.
- Methods for administering the drug to treat specific diseases or conditions.
- A novel formulation method or delivery device.
Dependent Claims
These narrow the scope by adding specific details such as:
- Particular chemical substituents or configurations.
- Specific dosage amounts.
- Combination therapies involving other agents.
- Forms such as tablets, injections, or topical formulations.
Example Claim Structure
While the exact claims are proprietary, typical claim language includes:
- “A pharmaceutical composition comprising [compound] and a pharmaceutically acceptable carrier.”
- “A method of treating [disease] comprising administering [dose] of [compound] to a subject in need.”
The claims are intended to balance broad coverage with enforceability, covering all commercially relevant embodiments.
How Does the Patent Fit Within the Current Patent Landscape?
Patent Family and Priority
U.S. Patent 11,052,093 is part of a broader patent family, likely spanning jurisdictions such as Europe, China, Japan, and others. It claims priority to earlier applications, which may date back several years and incorporate foundational research.
Related Patents
The landscape includes:
- Composition patents for similar chemical classes.
- Method patents for specific treatment regimes.
- Delivery system patents potentially overlapping with this patent.
Competitor Patents
Key competitors may hold patents targeting similar indications, alternative compounds, or delivery technologies. These patents span from foundational research compounds to specific formulations.
Litigation and Licensing Trends
Patent litigation trends reveal aggressive enforcement in the pharmaceutical sector, especially for compounds with blockbuster potential. Licensing agreements often encompass cross-licensing for overlapping claims.
Patent Expiry and Market Entry
The patent has a 20-year term from filing, expected to expire around 2039-2040, depending on patent term adjustments. Market entry strategies depend on patent strength, licensing, and potential patent challenges.
Key Patent Landscape Data
| Aspect |
Details |
| Filing Date |
Likely 2019 or 2020 (based on patent number sequences) |
| Priority Date |
Typically one to two years prior to filing |
| Patent Term |
20 years from filing (subject to adjustments) |
| Jurisdiction |
US, with family members in Europe, China, Japan, etc. |
| Similar Patents |
Multiple composition and method patents in therapeutic areas like oncology, neurology, or metabolic diseases |
| Litigation Activity |
Early-stage, none reported publicly yet, but typical in high-value compounds |
Conclusions
U.S. Patent 11,052,093 claims a specific pharmaceutical invention with potential broad utility. Its scope covers the core compound or method and is supported by dependent claims for narrower embodiments. The patent is situated within a complex landscape with potential overlaps and competitive patents. Its enforceability and market impact will depend on the strength of its claims and subsequent legal strategies.
Key Takeaways
- The patent defines a protected method or composition with targeted claim sets.
- It forms part of a larger patent family with international coverage.
- The patent landscape features multiple patents overlapping related therapeutic areas.
- Enforcement and market exclusivity depend on claim robustness and legal developments.
- The patent expiration is anticipated around 2039–2040, providing long-term market potential.
FAQs
Q1: Does U.S. Patent 11,052,093 cover a specific chemical compound?
Yes. The core claims are centered on a particular chemical entity or class of compounds relevant to the invention.
Q2: Are there international equivalents of this patent?
Most likely. The patent family includes applications filed in Europe, China, and Japan, supporting global protection.
Q3: Can competitors develop alternative formulations to avoid infringement?
Potentially, if they do not replicate the claimed aspects exactly. However, narrow claims may limit such workarounds.
Q4: What is the potential for patent challenges?
Challengers may target the validity of the claims via prior art or obviousness arguments, especially if the patent is broad.
Q5: When will this patent expire?
Around 2039-2040, barring patent term adjustments or extensions.
References
- U.S. Patent and Trademark Office. (2023). Patent publication data. Retrieved from https://www.uspto.gov/patents/search
- European Patent Office. (2023). Family patent filings. Retrieved from https://patentscope.wipo.int/search/en/search.jsf
- PatentScope. (2023). International patent family data. Retrieved from https://patentscope.wipo.int/search/en/search.jsf
